+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Beigene"

PARP Inhibitor Biomarkers Market by Product, by Service 1 & 2 Testing, by Application, by End-User, and By Region - Product Thumbnail Image

PARP Inhibitor Biomarkers Market by Product, by Service 1 & 2 Testing, by Application, by End-User, and By Region

  • Report
  • December 2024
  • 200 Pages
  • Global
From
Nasopharyngeal Cancer Market Analysis & Forecast to 2024-2034 - Product Thumbnail Image

Nasopharyngeal Cancer Market Analysis & Forecast to 2024-2034

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Liver Cancer Drug Global Market Report 2025 - Product Thumbnail Image

Liver Cancer Drug Global Market Report 2025

  • Report
  • January 2025
  • 175 Pages
  • Global
From
Antibody Drug Conjugates Global Market Opportunities and Strategies to 2033 - Product Thumbnail Image

Antibody Drug Conjugates Global Market Opportunities and Strategies to 2033

  • Report
  • July 2024
  • 303 Pages
  • Global
From
Immune Checkpoint Inhibitors - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Thumbnail Image

Immune Checkpoint Inhibitors - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • July 2024
  • 150 Pages
  • Global
From
Antibody Drug Conjugate - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Thumbnail Image

Antibody Drug Conjugate - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • July 2024
  • 150 Pages
  • Global
From
Esophageal Cancer - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Esophageal Cancer - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • February 2024
  • 245 Pages
  • Global
From
Checkpoint Inhibitors - Competitive landscape, 2023 - Product Thumbnail Image

Checkpoint Inhibitors - Competitive landscape, 2023

  • Report
  • April 2023
  • 350 Pages
  • Global
From
TIGIT Inhibitors - Competitive Landscape, 2022 - Product Thumbnail Image

TIGIT Inhibitors - Competitive Landscape, 2022

  • Report
  • October 2022
  • 100 Pages
  • Global
From
Head and Neck Cancer (HNC) - Market Insight, Epidemiology And Market Forecast - 2032 - Product Thumbnail Image

Head and Neck Cancer (HNC) - Market Insight, Epidemiology And Market Forecast - 2032

  • Report
  • September 2022
  • 239 Pages
  • Global
From
PD-(L)1 Inhibitors - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

PD-(L)1 Inhibitors - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • May 2024
  • 298 Pages
  • Global
From
Nasopharyngeal Cancer Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023 - 2028) - Product Thumbnail Image

Nasopharyngeal Cancer Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023 - 2028)

  • Report
  • April 2023
  • 118 Pages
  • Global
From
Immune Checkpoint Inhibitors Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023-2028) - Product Thumbnail Image

Immune Checkpoint Inhibitors Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023-2028)

  • Report
  • April 2023
  • 119 Pages
  • Global
From
Esophageal Cancer Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 - Product Thumbnail Image

Esophageal Cancer Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

  • Report
  • May 2024
  • 137 Pages
  • Global
From
Immune Checkpoint Inhibitors Market Report and Forecast 2024-2032 - Product Thumbnail Image

Immune Checkpoint Inhibitors Market Report and Forecast 2024-2032

  • Report
  • May 2024
  • 140 Pages
  • Global
From
Head And Neck Cancer - Pipeline Review, H2 2020 - Product Thumbnail Image

Head And Neck Cancer - Pipeline Review, H2 2020

  • Drug Pipelines
  • October 2020
  • 3419 Pages
  • Global
From
Oncology Drugs Market Size, Share & Industry Trends Analysis Report By Indication, By Drug Class Type (Targeted Therapy, Immunotherapy (Biologic Therapy), Chemotherapy and Hormonal Therapy), By Regional Outlook and Forecast, 2023 - 2030 - Product Thumbnail Image

Oncology Drugs Market Size, Share & Industry Trends Analysis Report By Indication, By Drug Class Type (Targeted Therapy, Immunotherapy (Biologic Therapy), Chemotherapy and Hormonal Therapy), By Regional Outlook and Forecast, 2023 - 2030

  • Report
  • November 2023
  • 306 Pages
  • Global
From
Immune Checkpoint Inhibitors Market Size, Share & Industry Trends Analysis Report By Application (Lung Cancer, Bladder Cancer, Melanoma, Hodgkin lymphoma, and others), By Type, By Regional Outlook and Forecast, 2021-2027 - Product Thumbnail Image

Immune Checkpoint Inhibitors Market Size, Share & Industry Trends Analysis Report By Application (Lung Cancer, Bladder Cancer, Melanoma, Hodgkin lymphoma, and others), By Type, By Regional Outlook and Forecast, 2021-2027

  • Report
  • February 2022
  • 185 Pages
  • Global
From
Metastatic Cancer Drugs Market Size, Share & Industry Trends Analysis Report By Distribution Channel, By Indication, By Therapy (Targeted Therapy, Immunotherapy, Hormonal Therapy and Chemotherapy), By Regional Outlook and Forecast, 2023 - 2030 - Product Thumbnail Image

Metastatic Cancer Drugs Market Size, Share & Industry Trends Analysis Report By Distribution Channel, By Indication, By Therapy (Targeted Therapy, Immunotherapy, Hormonal Therapy and Chemotherapy), By Regional Outlook and Forecast, 2023 - 2030

  • Report
  • July 2023
  • 290 Pages
  • Global
From
Gastric Cancer Market Size, Share & Industry Trends Analysis Report By Route of Administration (Injectable and Oral), By Treatment Type, By Disease Type, By Distribution Channel, By Drug Class, By Regional Outlook and Forecast, 2023-2029 - Product Thumbnail Image

Gastric Cancer Market Size, Share & Industry Trends Analysis Report By Route of Administration (Injectable and Oral), By Treatment Type, By Disease Type, By Distribution Channel, By Drug Class, By Regional Outlook and Forecast, 2023-2029

  • Report
  • April 2023
  • 326 Pages
  • Global
From
Loading Indicator

BeiGene is a market within the context of Oncology Drugs, which are drugs used to treat cancer. These drugs are used to target and destroy cancer cells, while minimizing damage to healthy cells. BeiGene is a biopharmaceutical company that develops and commercializes innovative molecularly targeted and immuno-oncology drugs for the treatment of cancer. The company focuses on developing therapies that target cancer cells with precision and accuracy, while also providing a safe and effective treatment for patients. BeiGene's portfolio includes a range of drugs, including small molecules, antibodies, and other biologics. The company also has a pipeline of novel therapies in development. BeiGene is one of many companies in the Oncology Drugs market. Other companies include AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Merck, Novartis, Pfizer, and Roche. Show Less Read more